This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
Blood
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (RKO)
Colon cancer cell (SW48)
Colon cancer cell (SW480)
Fetal human colon epithelial cell (FHC)
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Plasma
Saliva
Serum
By sample status
24 hr culture
72 hr culture
Cisplatin-resistant
Colorectal cancer_stage1
Colorectal cancer_stage1_after_resection
Colorectal cancer_stage2
Colorectal cancer_stage2_after_resection
Colorectal cancer_stage3a
Colorectal cancer_stage3a_after_resection
Colorectal cancer_stage3b
Colorectal cancer_stage3b_after_resection
Colorectal cancer_stage4
Colorectal cancer_stage4_after_resection
Extremely severe hand, foot, and mouth disease
Fetal bovine serum
Healthy_timepoint1
Healthy_timepoint2
Mild hand, foot, and mouth disease
Normal
Normal_Agilent
Normal_Exiqon
Omeprazole-treated
Oral lichen planus patient
Pancreatic cancer patient_Agilent
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Transplant islets into mouse xenotransplantation-rejected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-1207-5p
MIMAT0005871
0.0e+0
3.8e-2
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000596_1
52
/
0
/
52
hsa-miR-1207-5p
MIMAT0005871
0.0e+0
3.2e-2
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000596_1
52
/
0
/
52
hsa-miR-1207-5p
MIMAT0005871
0.0e+0
9.2e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000596_1
52
/
0
/
52
hsa-miR-1207-5p
MIMAT0005871
0.0e+0
3.4e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000596_1
52
/
0
/
52
hsa-miR-1207-5p
MIMAT0005871
6.7e-4
6.7e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000596_1
52
/
0
/
52
hsa-miR-1207-5p
MIMAT0005871
6.2e-4
6.2e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000596_1
52
/
0
/
52
<
[5]